Search Results

There are 32865 results for: content related to: High dose single-agent paclitaxel in a hemodialysis patient with advanced ovarian cancer: a case report with pharmacokinetic analysis and review of the literature

  1. You have free access to this content
    Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis

    International Journal of Cancer

    Volume 137, Issue 8, 15 October 2015, Pages: 2029–2039, Xiaoqian Yang, Jacson Shen, Yan Gao, Yong Feng, Yichun Guan, Zhan Zhang, Henry Mankin, Francis J. Hornicek and Zhenfeng Duan

    Version of Record online : 5 MAY 2015, DOI: 10.1002/ijc.29574

  2. Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 10, October 2013, Pages: 3748–3761, Firat Yerlikaya, Aysegul Ozgen, Imran Vural, Olgun Guven, Ergun Karaagaoglu, Mansoor A. Khan and Yilmaz Capan

    Version of Record online : 5 AUG 2013, DOI: 10.1002/jps.23686

  3. You have free access to this content
    P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel

    International Journal of Cancer

    Volume 132, Issue 10, 15 May 2013, Pages: 2439–2447, Jeroen J.M.A. Hendrikx, Jurjen S. Lagas, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen and Alfred H. Schinkel

    Version of Record online : 14 NOV 2012, DOI: 10.1002/ijc.27912

  4. Paclitaxel (Taxol)

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 14, Issue 1, January-February 1994, Pages: 3–34, David R. Kohler and Barry R. Goldspiel

    Version of Record online : 18 JAN 2012, DOI: 10.1002/j.1875-9114.1994.tb02785.x

  5. You have free access to this content
    Local delivery of paclitaxel in the treatment of peripheral arterial disease

    European Journal of Clinical Investigation

    Volume 45, Issue 3, March 2015, Pages: 333–345, Vivian G. Ng, Carlos Mena, Cody Pietras and Alexandra J. Lansky

    Version of Record online : 14 FEB 2015, DOI: 10.1111/eci.12407

  6. Flow Cytometric Identification of Paclitaxel-Accumulating Subpopulations

    Biotechnology Progress

    Volume 21, Issue 3, 2005, Pages: 978–983, Michael C. Naill and Susan C. Roberts

    Version of Record online : 5 SEP 2008, DOI: 10.1021/bp049544l

  7. Liquid–liquid extraction for recovery of paclitaxel from plant cell culture: Solvent evaluation and use of extractants for partitioning and selectivity

    Biotechnology Progress

    Volume 28, Issue 4, July/August 2012, Pages: 990–997, Timothy J. McPartland, Rohan A. Patil, Michael F. Malone and Susan C. Roberts

    Version of Record online : 18 JUN 2012, DOI: 10.1002/btpr.1562

  8. You have full text access to this OnlineOpen article
    Pharmacokinetic profile of paclitaxel in the plasma, lung, and diaphragm following intravenous or intrapleural administration in rats

    Thoracic Cancer

    Volume 6, Issue 1, January 2015, Pages: 43–48, Jie Li, Jian Tang, Yingjie Li, Jianqi Yu, Baoshi Zhang and Changhai Yu

    Version of Record online : 7 JAN 2015, DOI: 10.1111/1759-7714.12139

  9. You have free access to this content
    Development of two radioimmunoassays to detect paclitaxel in sera and in cerebrospinal, ascitic, and pleural fluids

    Cancer

    Volume 79, Issue 5, 1 March 1997, Pages: 1022–1030, Kevin P. O'Boyle, Yuexian Wang, Edward L. Schwartz, Donna Lee Regl, Avi Einzig, Janice P. Dutcher, Peter H. Wiernik and Susan Band Horwitz

    Version of Record online : 28 SEP 2000, DOI: 10.1002/(SICI)1097-0142(19970301)79:5<1022::AID-CNCR20>3.0.CO;2-2

  10. Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity

    The Journal of Pathology

    Volume 226, Issue 4, March 2012, Pages: 666–673, Xiaodong Sun, Dengwen Li, Yunfan Yang, Yuan Ren, Jingyu Li, Zaizhu Wang, Bin Dong, Min Liu and Jun Zhou

    Version of Record online : 17 JAN 2012, DOI: 10.1002/path.3026

  11. Efficacy of poly(sebacic acid-co-ricinoleic acid) biodegradable delivery system for intratumoral delivery of paclitaxel

    Journal of Biomedical Materials Research Part A

    Volume 92A, Issue 4, 15 March 2010, Pages: 1283–1291, Ariella Shikanov, Boris Vaisman, Sergey Shikanov and Abraham J. Domb

    Version of Record online : 2 APR 2009, DOI: 10.1002/jbm.a.32429

  12. Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes

    Journal of Pharmaceutical Sciences

    Volume 90, Issue 8, August 2001, Pages: 1091–1105, Robert B. Campbell, Sathyamangalam V. Balasubramanian and Robert M. Straubinger

    Version of Record online : 17 JUL 2001, DOI: 10.1002/jps.1063

  13. Polylactide-Based Paclitaxel-Loaded Nanoparticles Fabricated by Dispersion Polymerization: Characterization, Evaluation in Cancer Cell Lines, and Preliminary Biodistribution Studies

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 8, August 2014, Pages: 2546–2555, Simeon K. Adesina, Alesia Holly, Gabriela Kramer-Marek, Jacek Capala and Emmanuel O. Akala

    Version of Record online : 24 JUN 2014, DOI: 10.1002/jps.24061

  14. Self-Assembled Poly(butadiene)-b-poly(ethylene oxide) Polymersomes as Paclitaxel Carriers

    Biotechnology Progress

    Volume 23, Issue 1, 2007, Pages: 278–285, Shuliang Li, Belinda Byrne, JoEllen Welsh and Andre F. Palmer

    Version of Record online : 5 SEP 2008, DOI: 10.1021/bp060208

  15. Influence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxel

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 4, April 2011, Pages: 1444–1455, Jaclyn M. Hosmer, Soo H. Shin, Adwoa Nornoo, Haian Zheng and Luciana B. Lopes

    Version of Record online : 18 OCT 2010, DOI: 10.1002/jps.22370

  16. Pharmacokinetics of Paclitaxel in Ovarian Cancer Patients and Genetic Polymorphisms of CYP2C8, CYP3A4, and MDR1

    The Journal of Clinical Pharmacology

    Volume 45, Issue 6, June 2005, Pages: 674–682, Dr Miki Nakajima, Ms Yuto Fujiki, Dr Satoru Kyo, Dr Taro Kanaya, Dr Mitsuhiro Nakamura, Dr Yoshiko Maida, Dr Masaaki Tanaka, Dr Masaki Inoue and Dr Tsuyoshi Yokoi

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005276204

  17. Activation of TLR-4 to produce tumour necrosis factor-α in neuropathic pain caused by paclitaxel

    European Journal of Pain

    Volume 19, Issue 7, August 2015, Pages: 889–898, Z. Wu, S. Wang, I. Wu, M. Mata and D.J. Fink

    Version of Record online : 12 NOV 2014, DOI: 10.1002/ejp.613

  18. Pharmaceutical and physical properties of paclitaxel (taxol) complexes with cyclodextrins

    Journal of Pharmaceutical Sciences

    Volume 84, Issue 10, October 1995, Pages: 1223–1230, Uma S. Sharma, Sathyamangalam V. Balasubramanian and Robert M. Straubinger

    Version of Record online : 17 SEP 2006, DOI: 10.1002/jps.2600841015

  19. Paclitaxel-Loaded Stabilizer-Free Poly(D,L-lactide-co-glycolide) Nanoparticles Conjugated with Quantum Dots for Reversion of Anti-Cancer Drug Resistance and Cancer Cellular Imaging

    Journal of the Chinese Chemical Society

    Volume 56, Issue 5, October 2009, Pages: 923–934, Wen-Shuo Kuo, Yu-Cian Ku, Hei-Tin Sei, Fong-Yu Cheng and Chen-Sheng Yeh

    Version of Record online : 25 SEP 2013, DOI: 10.1002/jccs.200900136

  20. You have full text access to this OnlineOpen article
    A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs

    Journal of Veterinary Internal Medicine

    Volume 29, Issue 4, July/August 2015, Pages: 1006–1012, C. Khanna, M. Rosenberg and D. M. Vail

    Version of Record online : 14 JUL 2015, DOI: 10.1111/jvim.12596